My Bibliography

select

Algohary A, Zacharaki EI, Breto AL, Alhusseini M, Wallaengen V, Xu IR, Gaston SM, Punnen S, Castillo P, Pattany PM, Kryvenko ON, Spieler B, Abramowitz MC, Pra AD, Ford JC, Pollack A, Stoyanova R. Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique. NMR Biomed. 2024 Mar;37(3):e5069. doi: 10.1002/nbm.5069. Epub 2023 Nov 21. PubMed PMID: 37990759; NIHMSID:NIHMS1981683.

select

Stoyanova R, Zavala-Romero O, Kwon D, Breto AL, Xu IR, Algohary A, Alhusseini M, Gaston SM, Castillo P, Kryvenko ON, Davicioni E, Nahar B, Spieler B, Abramowitz MC, Dal Pra A, Parekh DJ, Punnen S, Pollack A. Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI. Cancers (Basel). 2023 Oct 31;15(21). doi: 10.3390/cancers15215240. PubMed PMID: 37958414; PubMed Central PMCID: PMC10647832.

select

Kryvenko ON, Punnen S, Udayakumar TS, Gaston SM, Tao W, Ma W, Stoyanova R, Pollack A. Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the Prostate. Int J Surg Pathol. 2023 Apr;31(2):184-189. doi: 10.1177/10668969221098080. Epub 2022 May 6. PubMed PMID: 35521917; NIHMSID:NIHMS1981684.

select

Algohary A, Alhusseini M, Breto AL, Kwon D, Xu IR, Gaston SM, Castillo P, Punnen S, Spieler B, Abramowitz MC, Dal Pra A, Kryvenko ON, Pollack A, Stoyanova R. Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. Cancers (Basel). 2022 Sep 15;14(18). doi: 10.3390/cancers14184475. PubMed PMID: 36139635; PubMed Central PMCID: PMC9496901.

select

Punnen S, Stoyanova R, Kwon D, Reis IM, Soodana-Prakash N, Ritch CR, Nahar B, Gonzalgo ML, Kava B, Liu Y, Arora H, Gaston SM, Castillo Acosta RP, Pra AD, Abramowitz M, Kryvenko ON, Davicioni E, Pollack A, Parekh DJ. Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy. J Urol. 2021 May;205(5):1344-1351. doi: 10.1097/JU.0000000000001559. Epub 2020 Dec 24. PubMed PMID: 33356482; PubMed Central PMCID: PMC8443270.

select

Grizzle WE, Kittles RA, Rais-Bahrami S, Shah E, Adams GW, DeGuenther MS, Kolettis PN, Nix JW, Bryant JE, Chinsky R, Kearns JE, Dehimer K, Terrin N, Chang H, Gaston SM. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy. Cancer Med. 2019 Nov;8(16):6915-6922. doi: 10.1002/cam4.2434. Epub 2019 Sep 30. PubMed PMID: 31568648; PubMed Central PMCID: PMC6853835.

select

Gaston SM, Grizzle WE, Rais-Bahrami S, Kearney GP. Nitrocellulose tissue prints: an innovative approach to preparing high quality DNA and RNA from prostate biopsies without compromising the cores for pathology diagnosis. Transl Androl Urol. 2018 Sep;7(Suppl 4):S514-S518. doi: 10.21037/tau.2018.09.01. PubMed PMID: 30363516; PubMed Central PMCID: PMC6178309.

select

Van Neste L, Groskopf J, Grizzle WE, Adams GW, DeGuenther MS, Kolettis PN, Bryant JE, Kearney GP, Kearney MC, Van Criekinge W, Gaston SM. Epigenetic risk score improves prostate cancer risk assessment. Prostate. 2017 Sep;77(12):1259-1264. doi: 10.1002/pros.23385. Epub 2017 Aug 1. PubMed PMID: 28762545.

select

Mosquera JM, Mehra R, Regan MM, Perner S, Genega EM, Bueti G, Shah RB, Gaston S, Tomlins SA, Wei JT, Kearney MC, Johnson LA, Tang JM, Chinnaiyan AM, Rubin MA, Sanda MG. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res. 2009 Jul 15;15(14):4706-11. doi: 10.1158/1078-0432.CCR-08-2927. Epub 2009 Jul 7. PubMed PMID: 19584163; PubMed Central PMCID: PMC3717524.

select

Lenkinski RE, Bloch BN, Liu F, Frangioni JV, Perner S, Rubin MA, Genega EM, Rofsky NM, Gaston SM. An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer. MAGMA. 2008 Nov;21(6):411-21. doi: 10.1007/s10334-008-0133-3. Epub 2008 Aug 28. PubMed PMID: 18752015; PubMed Central PMCID: PMC2739832.

select

Wang F, Wang L, Briggs C, Sicinska E, Gaston SM, Mamon H, Kulke MH, Zamponi R, Loda M, Maher E, Ogino S, Fuchs CS, Li J, Hader C, Makrigiorgos GM. DNA degradation test predicts success in whole-genome amplification from diverse clinical samples. J Mol Diagn. 2007 Sep;9(4):441-51. doi: 10.2353/jmoldx.2007.070004. Epub 2007 Aug 9. PubMed PMID: 17690213; PubMed Central PMCID: PMC1975106.

select

Gaston SM, Upton MP. Tissue print micropeel: a new technique for mapping tumor invasion in prostate cancer. Curr Urol Rep. 2006 Jan;7(1):50-6. doi: 10.1007/s11934-006-0038-5. Review. PubMed PMID: 16480669.

select

Hutchinson LM, Chang EL, Becker CM, Shih MC, Brice M, DeWolf WC, Gaston SM, Zetter BR. Use of thymosin beta15 as a urinary biomarker in human prostate cancer. Prostate. 2005 Jul 1;64(2):116-27. doi: 10.1002/pros.20202. PubMed PMID: 15666387.

select

Hutchinson LM, Chang EL, Becker CM, Ushiyama N, Behonick D, Shih MC, DeWolf WC, Gaston SM, Zetter BR. Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. Clin Biochem. 2005 Jun;38(6):558-71. doi: 10.1016/j.clinbiochem.2005.01.015. PubMed PMID: 15885237.

select

Gaston SM, Soares MA, Siddiqui MM, Vu D, Lee JM, Goldner DL, Brice MJ, Shih JC, Upton MP, Perides G, Baptista J, Lavin PT, Bloch BN, Genega EM, Rubin MA, Lenkinski RE. Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule. Nat Med. 2005 Jan;11(1):95-101. doi: 10.1038/nm1169. Epub 2004 Dec 26. PubMed PMID: 15619629.

select

DeWolf WC, Gaston SM. The cell cycle and its relevance to the urologist. J Urol. 2004 Apr;171(4):1674-81. doi: 10.1097/01.ju.0000115505.95189.24. Review. PubMed PMID: 15017265.

select

Sosna J, Rofsky NM, Gaston SM, DeWolf WC, Lenkinski RE. Determinations of prostate volume at 3-Tesla using an external phased array coil: comparison to pathologic specimens. Acad Radiol. 2003 Aug;10(8):846-53. doi: 10.1016/s1076-6332(03)00015-1. PubMed PMID: 12945918.

select

Zhou JR, Yu L, Zhong Y, Nassr RL, Franke AA, Gaston SM, Blackburn GL. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate. 2002 Oct 1;53(2):143-53. doi: 10.1002/pros.10141. PubMed PMID: 12242729; PubMed Central PMCID: PMC2777759.

select

Lin J, Hutchinson L, Gaston SM, Raab G, Freeman MR. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation. J Biol Chem. 2001 Aug 10;276(32):30127-32. doi: 10.1074/jbc.M010237200. Epub 2001 May 4. PubMed PMID: 11340068.

select

Gaston SM, Loughlin KR. Now what do we do with all these genes? Yeast-based two-hybrid analysis: an emerging technology for molecular urology in the post-genome era. Urology. 1999 Apr;53(4):835-42. doi: 10.1016/s0090-4295(98)00604-9. PubMed PMID: 10197871.

select

Gregor P, Gaston SM, Yang X, O'Regan JP, Rosen DR, Tanzi RE, Patterson D, Haines JL, Horvitz HR, Uhl GR. Genetic and physical mapping of the GLUR5 glutamate receptor gene on human chromosome 21. Hum Genet. 1994 Nov;94(5):565-70. doi: 10.1007/BF00211029. PubMed PMID: 7959697.

select

Ali G, Wasco W, Cai X, Szabo P, Sheu KF, Cooper AJ, Gaston SM, Gusella JF, Tanzi RE, Blass JP. Isolation, characterization, and mapping of gene encoding dihydrolipoyl succinyltransferase (E2k) of human alpha-ketoglutarate dehydrogenase complex. Somat Cell Mol Genet. 1994 Mar;20(2):99-105. doi: 10.1007/BF02290679. PubMed PMID: 8009371.

select

Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59-62. doi: 10.1038/362059a0. PubMed PMID: 8446170.

select

Tanzi R, Gaston S, Bush A, Romano D, Pettingell W, Peppercorn J, Paradis M, Gurubhagavatula S, Jenkins B, Wasco W. Genetic heterogeneity of gene defects responsible for familial Alzheimer disease. Genetica. 1993;91(1-3):255-63. doi: 10.1007/BF01436002. Review. PubMed PMID: 8125274.

select

Tanzi RE, Romano DM, Berger R, Buraczynska MJ, Gaston SM, Kurnit DM, Patterson D, Gusella JF, Stewart GD. Sequence-tagged sites (STSs) for a set of mapped markers on chromosome 21. Genomics. 1992 Oct;14(2):498-502. doi: 10.1016/s0888-7543(05)80251-4. PubMed PMID: 1427866.

select

Gaston SM, Marchase RB, Jakoi ER. Brain ligatin: a membrane lectin that binds acetylcholinesterase. J Cell Biochem. 1982;18(4):447-59. doi: 10.1002/jcb.1982.240180406. PubMed PMID: 7085778.

select

Jakoi ER, Kempe K, Gaston SM. Ligatin binds phosphohexose residues on acidic hydrolases. J Supramol Struct Cell Biochem. 1981;16(2):139-53. doi: 10.1002/jsscb.1981.380160205. PubMed PMID: 7299841.

select

Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique. NMR in biomedicine. . NIHMSID: NIHMS1981681.